Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic Saline Inhalation Prior to ELTGOL in Bronchiectasis
NCT06443658Phase 3Recruiting
- Sponsor
- Institut d'Investigació Biomèdica de Girona
- Start
- Jun 2024
- Primary completion
- Feb 2027
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of hypertonic saline in bronchiectasis, sponsored by Institut d'Investigació Biomèdica de Girona. Started Jun 2024; status: recruiting.
02
Drugs
hypertonic saline
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT06443658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06443658.